SIG-CompPath


MICCAI Special Interest Group on Computational Pathology

Mission

The focus of the Special Interest Group on “Computational Pathology” (SIG-CompPath) revolves around the development and application of novel imaging techniques and methods for clinical, pre-clinical, and non-clinical biomedical imaging.

Goals

Our goal is to bring together key stakeholders focused on the field of Computational Pathology, to make contributions and drive this field towards its full potential, ultimately making the transition from research to clinical practice. Such key stakeholders include, but are not limited to, computational and clinical researchers, opinion leaders, and equipment manufacturers.

The SIG also intends to build consensus regarding standards and best practices in the field of Computational Pathology, by fostering inclusivity and integrating the expertise of SIG-specific laboratories in academia and industry, from around the world.

Board Members

SIG-CompPath Board Members are committed to openness, transparency and knowledge dissemination among diverse academic, clinical, and industrial research groups.

SIG-CompPath members benefit from a stable infrastructure, open channels for communications and collaboration, consensus expert opinions, and guidance from leading experts as our community scales up and adopts tested processes and procedures to support its growth.

Executive

Spyros Bakas

President: 
Spyridon (Spyros) Bakas, PhD
Indiana University, USA

 

 

F Ciompi

Vice President: 
Francesco Ciompi, PhD, 
Radboud University Medical Center, Netherlands 

 

Anne Martel2

Treasurer: 
Anne Martel, PhD, 
Sunnybrook Research Institute, Canada

Additional Board Members

N.Rajpoot
Nasir Rajpoot, PhD, 
University of Warwick, UK

 



Geert Litjens


Geert Litjens, PhD, 
Radboud University Medical Center, Netherlands

 


Joe Yeong

Joe Yeong, MD, PhD, 
Singapore General Hospital, Singapore